BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 36843582)

  • 21. Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families.
    Daly AF; Vanbellinghen JF; Khoo SK; Jaffrain-Rea ML; Naves LA; Guitelman MA; Murat A; Emy P; Gimenez-Roqueplo AP; Tamburrano G; Raverot G; Barlier A; De Herder W; Penfornis A; Ciccarelli E; Estour B; Lecomte P; Gatta B; Chabre O; Sabaté MI; Bertagna X; Garcia Basavilbaso N; Stalldecker G; Colao A; Ferolla P; Wémeau JL; Caron P; Sadoul JL; Oneto A; Archambeaud F; Calender A; Sinilnikova O; Montañana CF; Cavagnini F; Hana V; Solano A; Delettieres D; Luccio-Camelo DC; Basso A; Rohmer V; Brue T; Bours V; Teh BT; Beckers A
    J Clin Endocrinol Metab; 2007 May; 92(5):1891-6. PubMed ID: 17244780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AIP mutations and gigantism.
    Rostomyan L; Potorac I; Beckers P; Daly AF; Beckers A
    Ann Endocrinol (Paris); 2017 Jun; 78(2):123-130. PubMed ID: 28483363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas.
    Leontiou CA; Gueorguiev M; van der Spuy J; Quinton R; Lolli F; Hassan S; Chahal HS; Igreja SC; Jordan S; Rowe J; Stolbrink M; Christian HC; Wray J; Bishop-Bailey D; Berney DM; Wass JA; Popovic V; Ribeiro-Oliveira A; Gadelha MR; Monson JP; Akker SA; Davis JR; Clayton RN; Yoshimoto K; Iwata T; Matsuno A; Eguchi K; Musat M; Flanagan D; Peters G; Bolger GB; Chapple JP; Frohman LA; Grossman AB; Korbonits M
    J Clin Endocrinol Metab; 2008 Jun; 93(6):2390-401. PubMed ID: 18381572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular diagnosis of pituitary adenoma predisposition caused by aryl hydrocarbon receptor-interacting protein gene mutations.
    Georgitsi M; Raitila A; Karhu A; Tuppurainen K; Mäkinen MJ; Vierimaa O; Paschke R; Saeger W; van der Luijt RB; Sane T; Robledo M; De Menis E; Weil RJ; Wasik A; Zielinski G; Lucewicz O; Lubinski J; Launonen V; Vahteristo P; Aaltonen LA
    Proc Natl Acad Sci U S A; 2007 Mar; 104(10):4101-5. PubMed ID: 17360484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Germline mutation in the aryl hydrocarbon receptor interacting protein gene in familial somatotropinoma.
    Toledo RA; Lourenço DM; Liberman B; Cunha-Neto MB; Cavalcanti MG; Moyses CB; Toledo SP; Dahia PL
    J Clin Endocrinol Metab; 2007 May; 92(5):1934-7. PubMed ID: 17341560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Familial acromegaly due to aryl hydrocarbon receptor-interacting protein (AIP) gene mutation in a Turkish cohort.
    Niyazoglu M; Sayitoglu M; Firtina S; Hatipoglu E; Gazioglu N; Kadioglu P
    Pituitary; 2014 Jun; 17(3):220-6. PubMed ID: 23743763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phenotypic and genotypic features of a large kindred with a germline AIP variant.
    Dal J; Nielsen EH; Klose M; Feldt-Rasmussen U; Andersen M; Vang S; Korbonits M; Jørgensen JOL
    Clin Endocrinol (Oxf); 2020 Aug; 93(2):146-153. PubMed ID: 32324286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutations in the aryl hydrocarbon receptor interacting protein gene are not highly prevalent among subjects with sporadic pituitary adenomas.
    Barlier A; Vanbellinghen JF; Daly AF; Silvy M; Jaffrain-Rea ML; Trouillas J; Tamagno G; Cazabat L; Bours V; Brue T; Enjalbert A; Beckers A
    J Clin Endocrinol Metab; 2007 May; 92(5):1952-5. PubMed ID: 17299063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutations of the gene for the aryl hydrocarbon receptor-interacting protein in pituitary adenomas.
    Cazabat L; Guillaud-Bataille M; Bertherat J; Raffin-Sanson ML
    Horm Res; 2009; 71(3):132-41. PubMed ID: 19188737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of AIP variants in pituitary adenomas and concomitant thyroid carcinomas in the Netherlands: a nationwide pathology registry (PALGA) study.
    Coopmans EC; Muhammad A; Daly AF; de Herder WW; van Kemenade FJ; Beckers A; de Haan M; van der Lely AJ; Korpershoek E; Neggers SJCMM
    Endocrine; 2020 Jun; 68(3):640-649. PubMed ID: 32333269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variable pathological and clinical features of a large Brazilian family harboring a mutation in the aryl hydrocarbon receptor-interacting protein gene.
    Naves LA; Daly AF; Vanbellinghen JF; Casulari LA; Spilioti C; Magalhães AV; Azevedo MF; Giacomini LA; Nascimento PP; Nunes RO; Rosa JW; Jaffrain-Rea ML; Bours V; Beckers A
    Eur J Endocrinol; 2007 Oct; 157(4):383-91. PubMed ID: 17893251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aryl hydrocarbon receptor interacting protein (AIP) gene mutation analysis in children and adolescents with sporadic pituitary adenomas.
    Georgitsi M; De Menis E; Cannavò S; Mäkinen MJ; Tuppurainen K; Pauletto P; Curtò L; Weil RJ; Paschke R; Zielinski G; Wasik A; Lubinski J; Vahteristo P; Karhu A; Aaltonen LA
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):621-7. PubMed ID: 18410548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetics of pituitary adenomas.
    Gadelha MR; Trivellin G; Hernández Ramírez LC; Korbonits M
    Front Horm Res; 2013; 41():111-40. PubMed ID: 23652674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic mutations in sporadic pituitary adenomas--what to screen for?
    Lecoq AL; Kamenický P; Guiochon-Mantel A; Chanson P
    Nat Rev Endocrinol; 2015 Jan; 11(1):43-54. PubMed ID: 25350067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pituitary Disease in
    Bilbao Garay I; Daly AF; Egaña Zunzunegi N; Beckers A
    J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32604740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Familial isolated pituitary adenomas (FIPA) and mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.
    Daly AF; Beckers A
    Endocrinol Metab Clin North Am; 2015 Mar; 44(1):19-25. PubMed ID: 25732638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: The roles of AIP and GPR101 in familial isolated pituitary adenomas (FIPA).
    Vasilev V; Daly AF; Trivellin G; Stratakis CA; Zacharieva S; Beckers A
    Endocr Relat Cancer; 2020 Aug; 27(8):T77-T86. PubMed ID: 32083999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel truncating AIP mutation, p.W279*, in a familial isolated pituitary adenoma (FIPA) kindred.
    Cansu GB; Taşkıran B; Trivellin G; Faucz FR; Stratakis CA
    Hormones (Athens); 2016 Jul; 15(3):441-444. PubMed ID: 27838609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular genetic testing in the management of pituitary disease.
    Coopmans EC; Korbonits M
    Clin Endocrinol (Oxf); 2022 Oct; 97(4):424-435. PubMed ID: 35349723
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.